Invention Grant
- Patent Title: EZH2 inhibitors for treating lymphoma
-
Application No.: US15319535Application Date: 2015-06-17
-
Publication No.: US10166238B2Publication Date: 2019-01-01
- Inventor: Heike Keilhack , Sarah K. Knutson , Danielle Johnston Blackwell , Larisa Reyderman , Lone Ottesen
- Applicant: Epizyme, Inc. , Eisai R&D Management Co., Ltd.
- Applicant Address: US MA Cambridge JP Tokyo
- Assignee: Epizyme, Inc.,Eisai R&D Management Co., Ltd.
- Current Assignee: Epizyme, Inc.,Eisai R&D Management Co., Ltd.
- Current Assignee Address: US MA Cambridge JP Tokyo
- Agency: Cooley LLP
- Agent Heidi A. Erlacher; Christine C. Pemberton
- International Application: PCT/US2015/036310 WO 20150617
- International Announcement: WO2015/195848 WO 20151223
- Main IPC: A61K31/5375
- IPC: A61K31/5375 ; A61K31/4427 ; A61K31/44 ; A61K31/5377 ; C07D213/65 ; C07D405/12 ; A61K31/4412 ; A61K31/4545
Abstract:
The present invention relates to compositions comprising inhibitors of human histone methyltransferase EZH2 and their use for the treatment of cancer.
Public/Granted literature
- US20170216300A1 EZH2 INHIBITORS FOR TREATING LYMPHOMA Public/Granted day:2017-08-03
Information query
